One of the major epigenetic alterations observed in hepatoblastoma (HB) is the hypermethylation of tumor suppressor genes, such as RASSF1A and CDKN2A, which contributes to their silencing [52,78]. This evidence concerns the gene CDKN2A and hemoglobin measurement.